Evidence map›Paper›PMID 34572316›Full record

ArticleBiomedicines2021

Prolyl-Isomerase Pin1 Controls Key fMLP-Induced Neutrophil Functions.

Samia Bedouhene, Min Liu, Nassima Senani, Tarek Boussetta, Coralie Pintard, Pham My-Chan Dang, Jamel El-Benna

Open access · goldAbstract read
In one paragraph

Article in Biomedicines, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.6field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Pathophysiology of Inflammatory Bowel Disease: Innate Immune System.International journal of molecular sciences · 2023
    Review
  7. The regulatory role of Pin1 in neuronal death.Neural regeneration research · 2023
    Review
  8. Neutrophils, Fast and Strong.Biomedicines · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 3 countries.

Samia BedouheneCentre de Recherche sur l'Inflammation, Laboratoire d'Excellence Inflamex, Faculté de Médecine Xavier Bichat, Université de Paris INSERM U1149, CNRS ERL 8252, 75018 Paris, France.
Min LiuCentre de Recherche sur l'Inflammation, Laboratoire d'Excellence Inflamex, Faculté de Médecine Xavier Bichat, Université de Paris INSERM U1149, CNRS ERL 8252, 75018 Paris, France.
Nassima SenaniLaboratoire de Biochimie Appliquée et de Biotechnologie, Faculté des Sciences Biologiques et des Sciences Agronomiques, Université Mouloud Mammeri, BPN 17, Tizi-Ouzou 15000, Algeria.ORCID 0000-0002-5825-1545
Tarek BoussettaCentre de Recherche sur l'Inflammation, Laboratoire d'Excellence Inflamex, Faculté de Médecine Xavier Bichat, Université de Paris INSERM U1149, CNRS ERL 8252, 75018 Paris, France.
Coralie PintardCentre de Recherche sur l'Inflammation, Laboratoire d'Excellence Inflamex, Faculté de Médecine Xavier Bichat, Université de Paris INSERM U1149, CNRS ERL 8252, 75018 Paris, France.
Pham My-Chan DangCentre de Recherche sur l'Inflammation, Laboratoire d'Excellence Inflamex, Faculté de Médecine Xavier Bichat, Université de Paris INSERM U1149, CNRS ERL 8252, 75018 Paris, France.
Jamel El-BennaCentre de Recherche sur l'Inflammation, Laboratoire d'Excellence Inflamex, Faculté de Médecine Xavier Bichat, Université de Paris INSERM U1149, CNRS ERL 8252, 75018 Paris, France.ORCID 0000-0001-5733-216X
Centre National de la Recherche Scientifique · FRMouloud Mammeri University of Tizi-Ouzou · DZ

Funding

Association Vaincre la Mucoviscidose 2020-2021Centre National de la Recherche Scientifique 2019-2025Institut National de la Santé et de la Recherche Médicale 2019-2025Université Paris Diderot 2018-2021
6 · The paper itself

Abstract

Neutrophils are key cells of the innate immune and inflammatory responses. They are the first blood cells to migrate to the infection site where they release high amounts of reactive oxygen species (ROS) and several peptides and enzymes required for microbial killing. However, excessive neutrophil activation can induce tissue injury participating in inflammation, thus the characterization of the enzymes involved in neutrophil activation could help to identify new pharmacological targets to treat inflammation. The prolyl-isomerase Pin1 is a ubiquitous enzyme involved in several functions, however, its role in neutrophil functions is less known. In this study, we show that the bacterial peptide N-formyl-methionyl-leucyl-phenylalanine (fMLP or fMLF), a G-protein coupled receptor (GPCR) agonist-induced Pin1 activation in human neutrophils. PiB and juglone, two Pin1 inhibitors inhibited Pin1 activity in neutrophils and consequently inhibited fMLP-induced chemotaxis and -degranulation of azurophil and specific granules as measured by myeloperoxidase and neutrophil gelatinase-associated lipocalin (NGAL) release respectively. We also showed that PiB inhibited TNFα + fMLP-induced superoxide production, confirming the effect of juglone. These data show that inhibitors of Pin1 impaired key pro-inflammatory neutrophil functions elicited by GPCR activation and suggest that Pin1 could control neutrophil inflammatory functions.

Indexed as

chemotaxisdegranulationfMLPinflammationjugloneneutrophilPiBPin1prolyl-isomeraserespiratory burst

Identifiers

PMID34572316
PMCPMC8472638
OpenAlexW3197499229

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.